False-positive quadruple screen test for trisomy 18 in a patient with a fetus with Bloom's syndrome

Laxmi Baxi, Stephen Brown, Harshwardhan Thaker

Research output: Contribution to journalArticle

Abstract

In the literature, conflicting reports on the significance of false-positive maternal serum multiple marker testing for trisomy 18 are encountered; however, the biology of this finding is discussed infrequently. We present such a case in association with Bloom's syndrome in the fetus. The fetus had intrauterine growth restriction, seen early in the second trimester, oligohydramnios, and was delivered at 34 weeks of gestation for impending fetal compromise. We propose that the adverse outcome of the pregnancy with false-positive serum analyte testing for trisomy 18 might result from a small-sized placenta and perhaps pathology at receptor level.

Original languageEnglish (US)
Pages (from-to)318-320
Number of pages3
JournalFetal Diagnosis and Therapy
Volume22
Issue number4
DOIs
StatePublished - Jun 1 2007
Externally publishedYes

Fingerprint

Bloom Syndrome
Fetus
Oligohydramnios
Second Pregnancy Trimester
Pregnancy Outcome
Placenta
Biomarkers
Mothers
Pathology
Pregnancy
Growth
Serum
Trisomy 18

Keywords

  • Bloom's syndrome
  • Trisomy 18

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Embryology
  • Radiology Nuclear Medicine and imaging
  • Obstetrics and Gynecology

Cite this

False-positive quadruple screen test for trisomy 18 in a patient with a fetus with Bloom's syndrome. / Baxi, Laxmi; Brown, Stephen; Thaker, Harshwardhan.

In: Fetal Diagnosis and Therapy, Vol. 22, No. 4, 01.06.2007, p. 318-320.

Research output: Contribution to journalArticle

@article{4e89494d50b04fe0acd0c154193728ec,
title = "False-positive quadruple screen test for trisomy 18 in a patient with a fetus with Bloom's syndrome",
abstract = "In the literature, conflicting reports on the significance of false-positive maternal serum multiple marker testing for trisomy 18 are encountered; however, the biology of this finding is discussed infrequently. We present such a case in association with Bloom's syndrome in the fetus. The fetus had intrauterine growth restriction, seen early in the second trimester, oligohydramnios, and was delivered at 34 weeks of gestation for impending fetal compromise. We propose that the adverse outcome of the pregnancy with false-positive serum analyte testing for trisomy 18 might result from a small-sized placenta and perhaps pathology at receptor level.",
keywords = "Bloom's syndrome, Trisomy 18",
author = "Laxmi Baxi and Stephen Brown and Harshwardhan Thaker",
year = "2007",
month = "6",
day = "1",
doi = "10.1159/000100799",
language = "English (US)",
volume = "22",
pages = "318--320",
journal = "Fetal Diagnosis and Therapy",
issn = "1015-3837",
publisher = "S. Karger AG",
number = "4",

}

TY - JOUR

T1 - False-positive quadruple screen test for trisomy 18 in a patient with a fetus with Bloom's syndrome

AU - Baxi, Laxmi

AU - Brown, Stephen

AU - Thaker, Harshwardhan

PY - 2007/6/1

Y1 - 2007/6/1

N2 - In the literature, conflicting reports on the significance of false-positive maternal serum multiple marker testing for trisomy 18 are encountered; however, the biology of this finding is discussed infrequently. We present such a case in association with Bloom's syndrome in the fetus. The fetus had intrauterine growth restriction, seen early in the second trimester, oligohydramnios, and was delivered at 34 weeks of gestation for impending fetal compromise. We propose that the adverse outcome of the pregnancy with false-positive serum analyte testing for trisomy 18 might result from a small-sized placenta and perhaps pathology at receptor level.

AB - In the literature, conflicting reports on the significance of false-positive maternal serum multiple marker testing for trisomy 18 are encountered; however, the biology of this finding is discussed infrequently. We present such a case in association with Bloom's syndrome in the fetus. The fetus had intrauterine growth restriction, seen early in the second trimester, oligohydramnios, and was delivered at 34 weeks of gestation for impending fetal compromise. We propose that the adverse outcome of the pregnancy with false-positive serum analyte testing for trisomy 18 might result from a small-sized placenta and perhaps pathology at receptor level.

KW - Bloom's syndrome

KW - Trisomy 18

UR - http://www.scopus.com/inward/record.url?scp=34250308069&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34250308069&partnerID=8YFLogxK

U2 - 10.1159/000100799

DO - 10.1159/000100799

M3 - Article

VL - 22

SP - 318

EP - 320

JO - Fetal Diagnosis and Therapy

JF - Fetal Diagnosis and Therapy

SN - 1015-3837

IS - 4

ER -